date,title,source
Oct-17-18,Todays Research Reports on Stocks to Watch: Altimmune and MannKind,ACCESSWIRE
Oct-24-18,"Research Report Identifies Cato, Roadrunner Transportation, Talend S.A, Vi, MannKind, and Acceleron Pharma with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
Oct-25-18,"MannKind Corporation to Hold 2018 Third Quarter Financial Results Conference Call on November 1, 2018",GlobeNewswire
Oct-31-18,United Therapeutics Corp (UTHR) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Nov-01-18,Edited Transcript of MNKD earnings conference call or presentation 1-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-01-18,MannKind: 3Q Earnings Snapshot,Associated Press
Nov-01-18,MannKind Corporation Reports 2018 Third Quarter Financial Results,GlobeNewswire
Nov-15-18,Edited Transcript of MNKD earnings conference call or presentation 1-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-16-18,Edited Transcript of MNKD earnings conference call or presentation 1-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-27-18,MannKind Appoints Christine Mundkur to its Board of Directors,GlobeNewswire
Nov-27-18,Analysts: Why United Therapeutics has had a streak of licensing deals,American City Business Journals
Dec-10-18,Biotech Stocks Beating the Market,ACCESSWIRE
Dec-11-18,MNKD: Zacks SCR Initiates Coverage of MannKind With $4.25/share Price Target,Zacks Small Cap Research
Dec-19-18,MannKind Announces Commencement of Public Offering,GlobeNewswire
Dec-20-18,How Many MannKind Corporation (NASDAQ:MNKD) Shares Do Institutions Own?,Simply Wall St.
Dec-20-18,Why MannKind Stock Is Plunging Today,Motley Fool
Dec-20-18,Today's Research Reports on Trending Tickers: Spectrum Pharmaceuticals and MannKind,ACCESSWIRE
Dec-27-18,MannKind Corporation to Hold Investor Conference Call,GlobeNewswire
Jan-17-19,How to spot risky biotech companies and six to avoid now,MarketWatch
Feb-05-19,Weekly CFO Buys Highlight,GuruFocus.com
Feb-05-19,"Market Trends Toward New Normal in MannKind, IDEX, Belden, Bright Horizons Family Solutions, Masonite International, and Veritiv  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Feb-19-19,"MannKind Corporation to Hold 2018 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2019",GlobeNewswire
Feb-20-19,MannKind Presents New Scientific Data at 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019),GlobeNewswire
Feb-20-19,MannKind Corporation Participating at Upcoming Conferences,GlobeNewswire
Feb-21-19,"The Daily Biotech Pulse: Genomic Health Earnings, AbbVie's Humira Approved For Another Indication In Japan",Benzinga
